NFKB1 and cancer: GSEA was performed to further discern the CLEC1B-related cancer hallmarks, and we found that CLEC1B expression was significantly associated with immune-related pathways, including “allograft rejection”, “inflammatory response”, “interferon gamma response”, “TNFA signaling via NFKB”, and “interferon alpha response” (Fig. 5B).